Piezo Motion partners with Benson Engineering to deliver affordable micro-precision motors and motion control solutions to the Southern U.S.
LAKEWOOD RANCH, Fla., March 10, 2022 (GLOBE NEWSWIRE) — via InvestorWire – Piezo Motion, a Brain Scientific (OTCQB:BRSF) company, and Benson Engineering today announce a partnership. Piezo Motion is a developer and leading manufacturer of automation technology. Benson Engineering, founded in 1946, is a family-owned manufacture representative group with offices in Texas and Missouri.
Benson Engineering works primarily with original equipment manufacturers (OEMs) in Texas, Louisiana, Oklahoma, Arkansas, Kansas, Missouri, Nebraska and Iowa. Piezo Motion’s multifaceted rotary and linear motors are built with technology that provides a stable, accurate motor that is designed specifically for OEMs that require ultimate speed, size and accuracy.
"We are looking forward to sharing the outstanding Piezo Motion platform with our customer and prospect base, expanding our value proposition with these clients who enjoy and look for next-level upgrades in motion technology,” said Alan Hobbs, vice president at Benson Engineering.
Piezo Motion motors are used globally for a variety of applications. These include laboratory instruments, biomedicine, optics, semiconductors, nanotechnology industries, and industrial electronic and automotive systems, along with an expanding portfolio of products that combine performance with dramatically lower cost over conventional piezo solutions.
“Our unique, tiny motors provide unparalleled precision and energy efficiencies to the market,” said Hassan Kotob, chairman and CEO of Brain Scientific. “Benson Engineering has been in the industry for more than 75 years and has a stellar reputation. We are looking forward to working with them and providing our precision motors to their customer base at an affordable price.”
About Piezo Motion
Piezo Motion (piezomotion.com), a Brain Scientific company, is a leader in precision motor technology with multimillion-dollar investments in research and development of affordable piezoelectric motors to meet, and exceed, the needs of today's global markets. The company is committed to the development of innovative technology and motion products that enhance functionality in a multitude of applications. The company works with startups, OEMs, research institutions and industrial companies from around the world, empowering the visionaries behind their products.
About Brain Scientific
Brain Scientific (brainscientific.com) is a medical technology company with multiple patents and FDA-cleared products. Brain Scientific is committed to developing next-gen solutions that advance the future of neurodiagnostic and OEM medical devices. Brain Scientific has two product lines covering neurology and precision motion. The NeuroCap and NeuroEEG are smart neurological diagnostic devices that simplify administration, shorten scan time, and cut costs. The Piezo Motion product line consists of ultra-efficient compact precision motors that will drive the next generation of medical devices. To learn more about Brain Scientific's corporate strategy, products, or investor relations, please visit brainscientific.com.
About Benson Engineering
Benson Engineering (bensonengineering.com) is a third-generation, family-owned, manufacture representative group founded in 1946. For more than 75 years, the company has strived to bring its customers quality products, outstanding service, and ethical standards beyond expectation. Benson Engineering’s personnel have all been with the company for a minimum of 20 years each giving long-standing expertise and experience in the territory with many OEMs and distributors.
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to the design, development and commercialization of EEG products and services and piezo motor technology; (ii) a projection of income (including income/loss), earnings (including earnings/loss) per share, capital expenditures, dividends, capital structure or other financial items; (iii) the company's future financial performance; (iv) the successful integration of Piezo Motion with and into Brain Scientific; and (v) the assumptions underlying or relating to any statement described in points (i), (ii), (iii) or (iv) above. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, over many of which the company has no control. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the company's inability to obtain additional financing; the significant length of time and resources associated with the development of products and related insufficient cash flows and resulting illiquidity; the company's inability to expand its business; significant government regulation of medical devices and the healthcare industry; lack of product diversification; volatility in the price of the company's raw materials; and the failure to implement the company's business plans or strategies. Some of these and other factors are identified and described in more detail in the company's filings with the SEC. The company does not undertake to update these forward-looking statements.
CONTACTS
INVESTORS
ir@brainscientific.com
MEDIA
pr@brainscientific.com
Corporate Communications
IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

Related Quotes
Yahoo Finance reporter Pras Subramanian details Rivian's miss on both the top and bottom line for Q4 earnings.
Bank of America Head of the Research Investment Committee Jared Woodard sits down with Yahoo Finance Live to talk about Amazon's announced 20-for-1 stock split and buyback program, and how tech companies implement these splits to their stock.
Russia is facing effective bankruptcy as soon as Wednesday after the World Bank warned that crippling sanctions have left the Kremlin “mighty close” to a default on its foreign debts.
Alibaba (BABA) American depository shares closed at 52-week lows following JD.com's (JD) quarterly print, and amid renewed worries over Chinese ADRs delistings off US exchanges.
The e-commerce giant's stock went into a tailspin based on a rumor. But a closer look show it's much ado about nothing.
It was the second quarter in a row that forecasts by the digital-signature company have fallen short of Street estimates and spurred a selloff in the stock.
MarketWatch Picks has highlighted these products and services because we think readers will find them useful; the MarketWatch News staff is not involved in creating this content. Consumer prices rose 7.9% in February, as compared to the same month in 2021, according to data from the Labor Department released in January. Now, U.S. inflation is at a nearly 40-year-high.
Rivian Automotive Inc. stock fell more than 12% late Thursday after the electric-vehicle maker posted a larger-than-expected quarterly loss and said that supply-chain snags and other problems persist.
Rivian (RIVN) reported its fourth quarter and full year 2021 financial results on Thursday after the closing bell. Shares of the EV startup fell as much as 10% immediately following the release.
(Bloomberg) — Wall Street’s embrace of Rivian Automotive Inc., last year’s electric-vehicle startup darling, is waning already as the company has lost about $117 billion in market value in just four months. Most Read from BloombergRussia Devises Plan to Seize Firms Abandoned in Foreigner ExodusUkraine Update: Zelenskiy Says 40,000 Evacuated, Attacks PersistUkraine Open to Russia's Neutrality Demand But Won’t Yield Territory, Aide SaysChina Warns U.S. Over Forming Pacific NATO, Backing TaiwanU.S
After Oracle Corp. Chief Financial Officer Safra Catz offered an in-line forecast and Larry Ellison knowingly laughed when asked about storing TikTok's data in the U.S. on Thursday afternoon, the software company's shares rebounded from a steep after-hours post-earnings decline.
Is the business really in as much trouble as it seems, or are investors overreacting, making Viatris a potentially appealing contrarian buy today? Viatris reported its year-end results on Feb. 28, and the numbers didn't necessarily look horrible. In its earnings release, Viatris also announced that it would be selling its biosimilars to Biocon Biologics for more than $3.3 billion in pre-tax consideration, calling it "the first in a series of expected initiatives anticipated to unlock up to an additional $6 billion in pre-tax proceeds by the end of 2023."
Money can't buy you happiness, but what about working with a financial advisor?
As of 11 a.m. ET, shares of both e-commerce platform provider Shopify (NYSE: SHOP) and the South American online retail giant MercadoLibre (NASDAQ: MELI) were down by about 6.8%. Meanwhile, Singapore-based Sea Limited (NYSE: SE), which operates the Shopee marketplace in Southeast Asia, was suffering an 8.5% meltdown. Late on Wednesday, for the first time this millennium, Amazon announced a stock split.
(Bloomberg) — The bet that Fidelity Investments made on retail investors who swarmed the stock market during the pandemic is paying off for Abigail Johnson and her family.Most Read from BloombergChina Warns U.S. Over Forming Pacific NATO, Backing TaiwanUkraine Open to Russia's Neutrality Demand But Won’t Yield Territory, Aide SaysOwners Fear Planes ‘Are Gone Forever’ After Russia Shields Them From SeizureChina Pushes Conspiracy Theory About U.S. Labs in UkraineUkraine Update: Firms Exit Russia,
Zor Capital Managing Director Joe Fahmy and KeyAdvisors Group's Eddie Ghabour join Yahoo Finance Live to discuss growth stocks amid the Fed's interest rate hikes and Russia-Ukraine pressures, planning around volatile risk, and investing patiently when the market dips.
While online gambling has attracted a lot of interest and generated additional revenue for DraftKings , the stock remains a trade and not a long-term hold, says Real Money contributor Stephen "Sarge" Guilfoyle. DraftKings stock is down more than 35% so far this year. "Would I buy this dip?" Guilfoyle asked.
DocuSign stock plunged after its January-quarter earnings met estimates and revenue topped views while guidance fell short.
Shares of electric truck maker Nikola (NASDAQ: NKLA) may be down more than 20% so far in 2022, but that's much less of a year-to-date decline than shareholders saw just a week ago. As the market headed toward the close on Thursday, Nikola shares were up about 18% for the week, according to data provided by S&P Global Market Intelligence. Nikola's fourth-quarter and full-year 2021 results were released on Feb. 24, and some of this week's momentum in the shares is still coming from that update.
Rival Chinese e-commerce company JD.com (NASDAQ: JD) reported a $0.5 per-share loss for its fiscal fourth quarter this morning. Reports on JD's loss blamed a slowing Chinese economy and weak consumer spending in the Middle Kingdom; both of these are trends that reinforce Alibaba's own assessment of slowing consumer spending, reported last month, and also confirm that the trend has continued for at least another month. Alibaba is arguably one of the strongest Chinese tech companies in existence, yet its share price is down 58% over the last 52 weeks.

source

Leave a Reply

Your email address will not be published.